Published Study Demonstrates Clinical Accuracy and Ease of Use of TRUE2go Blood Glucose Monitoring System from Home Diagnostics, Inc.
10/21/2009 8:42:10 AM
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Home Diagnostics, Inc. (NASDAQ:HDIX), a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, “Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips,” demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients. Diabetes Technology & Therapeutics is a peer-reviewed journal written for clinicians with the goal of promoting communication between developers and users of new diabetes treatment, monitoring, diagnosis and prevention technologies.
comments powered by